tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

Inventiva initiated with a Buy at TD Cowen
The FlyInventiva initiated with a Buy at TD Cowen
2d ago
IVA
Optimistic Buy Rating for Inventiva Driven by Lanifibranor’s Promising Phase 3 Prospects and Safety Profile
PremiumRatings
Optimistic Buy Rating for Inventiva Driven by Lanifibranor’s Promising Phase 3 Prospects and Safety Profile
2d ago
IVA
Inventiva & Japan’s Hepalys start lanifibranor clinical development program
PremiumThe Fly
Inventiva & Japan’s Hepalys start lanifibranor clinical development program
3d ago
IVA
Buy Rating for Inventiva: Strategic Focus on Lanifibranor and Strong Financial Outlook
PremiumRatings
Buy Rating for Inventiva: Strategic Focus on Lanifibranor and Strong Financial Outlook
9d ago
IVA
Inventiva publishes lanifibranor trial results in Journal of Hepatology
PremiumThe Fly
Inventiva publishes lanifibranor trial results in Journal of Hepatology
25d ago
IVA
Inventiva price target lowered to $17 from $20 at Stifel
PremiumThe FlyInventiva price target lowered to $17 from $20 at Stifel
3M ago
IVA
Inventiva reports revenues for irst nine months FY24 EUR 1.3M
Premium
The Fly
Inventiva reports revenues for irst nine months FY24 EUR 1.3M
3M ago
IVA
Inventiva initiated with a Neutral at UBS
Premium
The Fly
Inventiva initiated with a Neutral at UBS
3M ago
IVA
Inventiva announces DMC recommendation to continue NATiV3 trial as is
PremiumThe Fly
Inventiva announces DMC recommendation to continue NATiV3 trial as is
4M ago
IVA
Inventiva price target lowered to $13 from $14 at H.C. Wainwright
PremiumThe Fly
Inventiva price target lowered to $13 from $14 at H.C. Wainwright
4M ago
IVA
Inventiva announces financing of up to EUR 348M to advance NATiV3 Phase 3 study
PremiumThe Fly
Inventiva announces financing of up to EUR 348M to advance NATiV3 Phase 3 study
4M ago
IVA
Sifel says financing should bring Inventiva’s Lani ‘over the finish line’
PremiumThe Fly
Sifel says financing should bring Inventiva’s Lani ‘over the finish line’
4M ago
IVA
Inventiva price target lowered to $14 from $22 at H.C. Wainwright
PremiumThe FlyInventiva price target lowered to $14 from $22 at H.C. Wainwright
5M ago
IVA
Inventiva price target lowered to $20 from $25 at Stifel
Premium
The Fly
Inventiva price target lowered to $20 from $25 at Stifel
5M ago
IVA
Inventiva reports 1H EPS EUR (94c) vs. EUR ($1.31) in 1H last year
Premium
The Fly
Inventiva reports 1H EPS EUR (94c) vs. EUR ($1.31) in 1H last year
5M ago
IVA
Inventiva granted patent by JPO for protecting use of lanifibranor
PremiumThe Fly
Inventiva granted patent by JPO for protecting use of lanifibranor
7M ago
IVA
Inventiva seen as an undervalued MASH asset, says Canaccord
PremiumThe Fly
Inventiva seen as an undervalued MASH asset, says Canaccord
9M ago
IVA
Inventiva announces positive recommendation from DMC meeting on NATiV3 trial
PremiumThe Fly
Inventiva announces positive recommendation from DMC meeting on NATiV3 trial
9M ago
IVA
Inventiva price target raised to $20 from $12 at Canaccord
PremiumThe Fly
Inventiva price target raised to $20 from $12 at Canaccord
11M ago
IVA
Inventiva announces LEGEND trial meets primary endpoint
PremiumThe FlyInventiva announces LEGEND trial meets primary endpoint
11M ago
IVA
Inventiva lifts pause on screening for NATiV3 clinical trial
Premium
The Fly
Inventiva lifts pause on screening for NATiV3 clinical trial
12M ago
IVA
Inventiva price target lowered to $22 from $24 at H.C. Wainwright
Premium
The Fly
Inventiva price target lowered to $22 from $24 at H.C. Wainwright
1y ago
IVA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >